Hong Liang, Yue Hong, Cai Dunpeng, DeHart Autumn, Toloza-Alvarez Gretel, Du Lili, Zhou Xianwu, Fan Xiaoping, Huang Huanlei, Chen Shiyou, Rahaman Shaik O, Zhuang Jian, Li Wei
Department of Cardiac Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Department of Biomedical Sciences, Joan C. Edwards School of Medicine at Marshall University, Huntington, West Virginia, USA.
Cardiovasc Ther. 2024 Dec 18;2024:1129181. doi: 10.1155/cdr/1129181. eCollection 2024.
Thymidine phosphorylase (TYMP) promotes platelet activation and thrombosis while suppressing vascular smooth muscle cell (VSMC) proliferation. Both processes are central to the development and progression of abdominal aortic aneurysms (AAAs). We hypothesize that TYMP plays a role in AAA development. Male wild-type (WT) C57BL/6J and mice, fed a Western diet (WD) (TD.88137), were subjected to the 4-week Ang II infusion-induced AAA model. AAA progression was monitored by echography and confirmed through necropsy. Whole-body inflammation was assessed using a plasma cytokine array. Mechanistic studies were conducted using TYMP-overexpressing rat VSMC cell lines and primary VSMCs cultured from WT and mouse thoracic aortas. Histological studies were performed on human AAA and normal aorta samples. Elevated TYMP levels were observed in human AAA vessel walls. While WT mice exhibited a 28.6% prevalence of Ang II infusion-induced AAA formation, mice were protected. TYMP enhanced MMP2 expression, secretion, and activation in VSMCs, which was inhibited by tipiracil, a selective TYMP inhibitor. Systemically, TYMP promoted proinflammatory cytokine expression, and its absence attenuated TNF--induced MMP2 and AKT activation. WT VSMCs treated with platelets lacking TYMP showed a higher proliferation rate than cells treated with WT platelets. Additionally, TYMP increased activated TGF1 expression in cultured VSMCs and human AAA vessel walls. In WT VSMCs, TYMP augmented thrombospondin-1 type 1 repeat domain (TSR)-stimulated TGF1 signaling, increasing connective tissue growth factor and MMP2 production. TSR also enhanced AKT activation in WT VSMCs but had the opposite effect in cells. TSR-enhanced MMP2 activation in WT VSMCs was attenuated by LY294002 (a PI3K inhibitor) but not by SB431542 (a TGF1 inhibitor); both inhibitors had indiscernible effects on VSMC. TYMP emerges as a novel regulatory force in vascular biology, influencing VSMC function and inflammatory responses to promote AAA development.
胸苷磷酸化酶(TYMP)促进血小板活化和血栓形成,同时抑制血管平滑肌细胞(VSMC)增殖。这两个过程都是腹主动脉瘤(AAA)发生和发展的核心。我们假设TYMP在AAA的发展中起作用。给雄性野生型(WT)C57BL/6J小鼠和基因敲除小鼠喂食西式饮食(WD)(TD.88137),使其接受4周血管紧张素II输注诱导的AAA模型。通过超声检查监测AAA进展,并通过尸检确认。使用血浆细胞因子阵列评估全身炎症。使用过表达TYMP的大鼠VSMC细胞系和从WT和基因敲除小鼠胸主动脉培养的原代VSMC进行机制研究。对人AAA和正常主动脉样本进行组织学研究。在人AAA血管壁中观察到TYMP水平升高。虽然WT小鼠中血管紧张素II输注诱导的AAA形成患病率为28.6%,但基因敲除小鼠受到保护。TYMP增强了VSMC中MMP2的表达、分泌和激活,这被选择性TYMP抑制剂替吡嘧啶抑制。在全身水平上,TYMP促进促炎细胞因子表达,其缺失减弱了TNF-α诱导的MMP2和AKT激活。用缺乏TYMP的血小板处理的WT VSMC显示出比用WT血小板处理的细胞更高的增殖率。此外,TYMP增加了培养的VSMC和人AAA血管壁中活化TGF1的表达。在WT VSMC中,TYMP增强了血小板反应蛋白-1 1型重复结构域(TSR)刺激的TGF1信号传导,增加了结缔组织生长因子和MMP2的产生。TSR还增强了WT VSMC中的AKT激活,但在基因敲除细胞中具有相反的作用。LY294002(一种PI3K抑制剂)减弱了TSR增强的WT VSMC中MMP2的激活,但SB431542(一种TGF1抑制剂)没有;两种抑制剂对基因敲除VSMC均无明显作用。TYMP成为血管生物学中的一种新型调节力量,影响VSMC功能和炎症反应以促进AAA的发展。